Cargando…

A hypoxia‐related lncRNA model for prediction of head and neck squamous cell carcinoma prognosis

BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is one of the most common and highly heterogeneous malignancies worldwide. Increasing studies have proven that hypoxia and related long non‐coding RNA (lncRNA) are involved in the occurrence and prognosis of HNSCC. The goal of this work is to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiang, Junwei, He, Yaodong, Li, Yunshan, Wu, Kexuan, Cheng, Mengxiang, Wang, Yuanyin, Chen, Ran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939198/ https://www.ncbi.nlm.nih.gov/pubmed/35920349 http://dx.doi.org/10.1002/cam4.5102

Ejemplares similares

PES1 is a biomarker of head and neck squamous cell carcinoma and is associated with the tumor microenvironment
por: He, Yaodong, et al.
Publicado: (2023)

TYK2 correlates with immune infiltration: A prognostic marker for head and neck squamous cell carcinoma
por: He, Yaodong, et al.
Publicado: (2022)

Identification of a Hypoxia-Related lncRNA Biomarker Signature for Head and Neck Squamous Cell Carcinoma
por: Yang, Cuifang, et al.
Publicado: (2022)

Circular RNA-related CeRNA network and prognostic signature for patients with oral squamous cell carcinoma
por: He, Yaodong, et al.
Publicado: (2022)

Hypoxia-Regulated lncRNA USP2-AS1 Drives Head and Neck Squamous Cell Carcinoma Progression
por: Tang, Jianmin, et al.
Publicado: (2022)

Identification of Ferroptosis-Related lncRNA Pairs for Predicting the Prognosis of Head and Neck Squamous Cell Carcinoma
por: Wu, Congxiao, et al.
Publicado: (2022)

MicroRNA in adenoid cystic carcinoma (Review)
por: Li, Yunshan, et al.
Publicado: (2022)

Immune-related lncRNA classification of head and neck squamous cell carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2022)

LncRNA AL161431.1 predicts prognosis and drug response in head and neck squamous cell carcinoma
por: Zhou, Mingzhu, et al.
Publicado: (2023)

lncRNA Profiles Enable Prognosis Prediction and Subtyping for Esophageal Squamous Cell Carcinoma
por: Zhang, Shujun, et al.
Publicado: (2021)

Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas
por: Kolenda, Tomasz, et al.
Publicado: (2019)

An immune‐related seven‐lncRNA signature for head and neck squamous cell carcinoma
por: Chen, Yue, et al.
Publicado: (2021)

The Functional Mechanism of MicroRNA in Oral Lichen Planus
por: Li, Yunshan, et al.
Publicado: (2022)

PRINS lncRNA Is a New Biomarker Candidate for HPV Infection and Prognosis of Head and Neck Squamous Cell Carcinomas
por: Kopczyńska, Magda, et al.
Publicado: (2020)

Identification of Immune-Related LncRNA Pairs for Predicting Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma
por: Wang, Xueying, et al.
Publicado: (2021)

Predicting the Immune Microenvironment and Prognosis with a NETosis-Related lncRNA Signature in Head and Neck Squamous Cell Carcinoma
por: He, Xiaohua, et al.
Publicado: (2022)

Cuproptosis-related lncRNA SNHG16 as a biomarker for the diagnosis and prognosis of head and neck squamous cell carcinoma
por: Han, Baoai, et al.
Publicado: (2023)

Identification of lncRNA Signature of Tumor-Infiltrating T Lymphocytes With Potential Implications for Prognosis and Chemotherapy of Head and Neck Squamous Cell Carcinoma
por: Wang, Liping, et al.
Publicado: (2022)

Construction of a necroptosis‐related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma
por: Huang, Juntao, et al.
Publicado: (2022)

A novel necroptosis-related LncRNA signature for prediction of prognosis and therapeutic responses of head and neck squamous cell carcinoma
por: Meng, Zilu, et al.
Publicado: (2022)

Identification of immune‐related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2022)

Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma
por: Xu, Qiu-Shuang, et al.
Publicado: (2022)

Identification of a cuproptosis-related lncRNA signature to predict the prognosis and immune landscape of head and neck squamous cell carcinoma
por: Huang, Juntao, et al.
Publicado: (2022)

A cuproptosis-related lncRNA signature predicts the prognosis and immune cell status in head and neck squamous cell carcinoma
por: Zheng, Xiwang, et al.
Publicado: (2023)

A Prognostic 5-lncRNA Expression Signature for Head and Neck Squamous Cell Carcinoma
por: Liu, Guancheng, et al.
Publicado: (2018)

LncRNA PVT1 promotes malignant progression in squamous cell carcinoma of the head and neck
por: Yu, Changyun, et al.
Publicado: (2018)

Clusterization in head and neck squamous carcinomas based on lncRNA expression: molecular and clinical correlates
por: de Lena, Pelayo G., et al.
Publicado: (2017)

The Role of lncRNA Crosstalk in Leading Cancer Metastasis of Head and Neck Squamous Cell Carcinoma
por: Wang, Yu, et al.
Publicado: (2020)

Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma
por: Wang, Jian, et al.
Publicado: (2021)

Construction of artificial neural network diagnostic model and analysis of immune infiltration for periodontitis
por: Xiang, Junwei, et al.
Publicado: (2022)

Liquid lncRNA Biopsy for the Evaluation of Locally Advanced and Metastatic Squamous Cell Carcinomas of the Head and Neck
por: Łasińska, Izabela, et al.
Publicado: (2020)

The role of NEAT1 lncRNA in squamous cell carcinoma of the head and neck is still difficult to define
por: Kozłowska, Joanna, et al.
Publicado: (2020)

Development and Validation of an Autophagy-Related LncRNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Shen, Lin, et al.
Publicado: (2021)

Immune-Related lncRNA Signature for Predicting the Immune Landscape of Head and Neck Squamous Cell Carcinoma
por: Yin, Ji, et al.
Publicado: (2021)

Hypoxia in Head and Neck Squamous Cell Carcinoma
por: Li, John Zenghong, et al.
Publicado: (2012)

Hypoxia-related LncRNAs signature predicts prognosis and is associated with immune infiltration and progress of head and neck squamous cell carcinoma
por: Li, Minhan, et al.
Publicado: (2022)

A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC)
por: Wang, Peng, et al.
Publicado: (2018)

Identification and Clinical Validation of 4-lncRNA Signature for Predicting Survival in Head and Neck Squamous Cell Carcinoma
por: Ji, Yanping, et al.
Publicado: (2020)

Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Pan, Yunbao, et al.
Publicado: (2019)

Seven LncRNA-mRNA based risk score predicts the survival of head and neck squamous cell carcinoma
por: Zhang, Zhi-Li, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5b3qp5sjknm5qc37rs1vrbncml